Figure 2
Figure 2. Increased release of immature K-RASG12D–expressing myeloid cells in the setting of Rce1 deficiency. (A) White blood cells were evaluated in blood smears from Rce1fl/flKLSLM (▪; n = 6) and Rce1fl/+KLSLM mice (□; n = 6) harvested before and after pI-pC injections. Immature cells (myeloblasts, promyelocytes, promonocytes, myelocytes, metamyelocytes, band cells, pelgeroid cells) (A) and lymphocytes (B) are plotted as percentages of total white blood cells. Differences between Rce1fl/flKLSLM and Rce1fl/+KLSLM mice were evident 3 weeks after pI-pC injection, and the proportions did not change over time. Thus, data from 3, 5, and 7 weeks were combined. (C) Photographs of blood smears from before and 5 weeks after pI-pC injections (magnification: 100×/1.30 NA oil-immersion objective lens). (Top right panel) Arrowhead, pelgeroid cell; arrow, band cell; large cell in center, myeloblast.

Increased release of immature K-RASG12D–expressing myeloid cells in the setting of Rce1 deficiency. (A) White blood cells were evaluated in blood smears from Rce1fl/flKLSLM (▪; n = 6) and Rce1fl/+KLSLM mice (□; n = 6) harvested before and after pI-pC injections. Immature cells (myeloblasts, promyelocytes, promonocytes, myelocytes, metamyelocytes, band cells, pelgeroid cells) (A) and lymphocytes (B) are plotted as percentages of total white blood cells. Differences between Rce1fl/flKLSLM and Rce1fl/+KLSLM mice were evident 3 weeks after pI-pC injection, and the proportions did not change over time. Thus, data from 3, 5, and 7 weeks were combined. (C) Photographs of blood smears from before and 5 weeks after pI-pC injections (magnification: 100×/1.30 NA oil-immersion objective lens). (Top right panel) Arrowhead, pelgeroid cell; arrow, band cell; large cell in center, myeloblast.

Close Modal

or Create an Account

Close Modal
Close Modal